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Extensive human genome transcription <p>RACE sequencing of ENCODE regions shows that much of the human genome is represented in poly(A)+ RNA.</p>
Abstract
Background: Recent studies of the mammalian transcriptome have revealed a large number of
additional transcribed regions and extraordinary complexity in transcript diversity. However, there
is still much uncertainty regarding precisely what portion of the genome is transcribed, the exact
structures of these novel transcripts, and the levels of the transcripts produced.
Results: We have interrogated the transcribed loci in 420 selected ENCyclopedia Of DNA
Elements (ENCODE) regions using rapid amplification of cDNA ends (RACE) sequencing. We
analyzed annotated known gene regions, but primarily we focused on novel transcriptionally active
regions (TARs), which were previously identified by high-density oligonucleotide tiling arrays and
on random regions that were not believed to be transcribed. We found RACE sequencing to be
very sensitive and were able to detect low levels of transcripts in specific cell types that were not
detectable by microarrays. We also observed many instances of sense-antisense transcripts; further
analysis suggests that many of the antisense transcripts (but not all) may be artifacts generated from
the reverse transcription reaction. Our results show that the majority of the novel TARs analyzed
(60%) are connected to other novel TARs or known exons. Of previously unannotated random
regions, 17% were shown to produce overlapping transcripts. Furthermore, it is estimated that 9%
of the novel transcripts encode proteins.
Conclusion: We conclude that RACE sequencing is an efficient, sensitive, and highly accurate
method for characterization of the transcriptome of specific cell/tissue types. Using this method, it
appears that much of the genome is represented in polyA+ RNA. Moreover, a fraction of the novel
RNAs can encode protein and are likely to be functional.
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Background
Recent studies [1-5] have revealed that the composition and
structure of the mammalian transcriptome is much more
complex than was previously thought. Large-scale RT-PCR
analysis to determine the structure of transcripts produced
from exons of known human genes has shown that multiple
transcripts are produced from most gene loci (an average of
more than five was reported by Harrow and coworkers [6]).
In many cases the 5' ends of these alternate transcripts are
located more than 100 kilobases upstream from the previ-
ously known start site [1]. Likewise, systematic analysis of
cloned mouse and human cDNAs revealed that many more
transcripts than previously appreciated are transcribed from
each known gene locus [7-9]. One source of complexity is
alternative 5' ends; recent studies indicate that there are at
least 36% more promoters than was previously recognized
[10-14].
In addition to the diversity of transcripts from known loci, it
appears that much more of the human genome is transcribed
than was previously appreciated. Probing of tiling arrays with
cDNA probes has indicated that there are at least twice as
many transcribed regions of the human genome than had
previously been annotated [3,15-18]. Rapid amplification of
cDNA ends (RACE) analysis using primers designed to these
novel transcribed regions (called transcriptionally active
regions [TARs] or TransFrags) followed by hybridization to
arrays confirms the transcription of these regions. However,
this array analysis does not reveal information concerning
transcript structure or abundance. The large number of these
transcripts along with the fact that many long transcripts are
produced suggest that much of the human genome is tran-
scribed, at least at some level.
The different cDNA and tiling array studies to analyze tran-
scription have also revealed extensive antisense transcription
in mammalian genomes [2,19]. One concern is that these
studies often use reverse transcription to create single-
stranded cDNA, but this may also cause second strand syn-
thesis. Thus, it is unclear whether the detected expression
from the second strand is due to bona fide antisense tran-
scription or a result of a probe made for the second strand.
These various studies have raised many more questions than
have been answered. How much of the human genome pro-
duces transcripts that are present in the mRNA population?
What is the nature of the transcripts produced by the novel
transcribed regions? What fraction of novel transcribed
regions is likely to be protein coding? What is the level of tran-
scripts produced from the novel transcribed regions? Finally,
how much antisense transcription occurs in human cells?
In an effort to address some of these questions and thereby
better characterize the human genome and its gene annota-
tion, we have systematically analyzed the transcribed loci in
420 selected portions of the ENCyclopedia Of DNA Elements
(ENCODE) regions using 5'-RACE and 3'-RACE sequencing.
The ENCODE regions are 44 regions that comprise 1% of the
human genome and have been highly characterized with
respect to transcripts and transcription factor binding [1].
Highly sensitive RACE sequencing provides new insight into
the human genome and its transcription. We found that many
genes not known to be expressed in a particular cell type pro-
duce properly spliced low abundance transcripts. We also
found that in some cases the purported antisense transcrip-
tion is likely to be an artifact of the reverse transcription reac-
tion. Additionally, we systematically analyzed, for the first
time, the structure and level of transcripts produced from
many novel transcribed regions and from regions that were
not known to be transcribed. RACE sequences derived from
novel TARs showed that these regions are highly connected,
and revealed the structure of several potential novel protein
coding transcripts. Finally, we uncovered transcription in
previous nontranscribed regions of the genome, demonstrat-
ing that much of the genome is transcribed. Overall, these
studies significantly enhance our understanding of the tran-
scriptome of the human genome.
Results
Overview of 5'-RACE and 5'-RACE sequencing 
experiments in selected ENCODE regions
We have studied the transcripts produced from annotated
gene regions, novel TARs previously identified by high-den-
sity oligonucleotide tiling arrays, and regions that were not
previously shown to be transcribed (nonTx regions) using 5'-
RACE and 3'-RACE and DNA sequencing [15,18,20]. The
chromosomal regions for our analysis are primarily from the
ENCODE regions of chromosome 22, which is particularly
well annotated, as well as additional ENCODE regions on
chromosomes 11 and 21. The RNAs analyzed were from NB4
acute promyelocytic leukemia cells, HeLa cells, and placental
tissue. Both polyA+ and total RNA were used. A summary of
the experiments performed is presented in Table 1.
In total, 420 regions were analyzed; primers to each strand
were designed and subjected to 5'-RACE and 3'-RACE reac-
tions for a total of 1,680 reactions. Approximately 80% of the
reactions generated products that were detected by gel elec-
trophoresis (see Additional data file 1 for examples); 25% of
these reactions yielded heterogeneous products (smears).
The entire PCR reaction was subjected to DNA sequence anal-
ysis, and approximately 40% of the sequence reads mapped to
the expected locations of the genome and were therefore
deemed as products derived for the intended locus (see Mate-
rials and methods, below, for details regarding mapping of
RACE sequences to the genome and the fitness score assign-
ment). The average length of these sequence reads is 516 base
pairs (bp). As expected, primers designed in known exons
gave the highest proportion of valid RACE products. This is
followed by the primers designed to the novel TARs. Thehttp://genomebiology.com/2008/9/1/R3 Genome Biology 2008,     Volume 9, Issue 1, Article R3       Wu et al. R3.3
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nonTx regions gave the fewest RACE products (Figure 1).
Similar results were observed with both polyA+ and total
RNAs, as well as from human cell lines or tissue.
RACE sequencing is highly sensitive in detecting 
transcripts expressed at a low level
We first analyzed the RACE sequences from eight known gene
loci. For six of these loci we analyzed RNA from cells in which
the gene was known to be expressed. For two genes, 5'-RACE
and 3'-RACE reactions were performed using primers
designed to the forward and reverse strand of each exon. For
an additional four genes we analyzed a subset (1 to 8) of exons
in the gene. As shown in Figure 2, the sequences of the known
loci mostly matched the known annotations. For example,
analysis of the DRG1 and FBXO7 genes, which are known to
be expressed in NB4 cells, revealed cDNA sequences that
matched the expected transcripts described in Refseq. In
addition to detecting known transcripts, we also found novel
isoforms. Some of these isoforms contained new exons
whereas others contained different combinations of the
known exons. An example is shown in Figure 2b for FBXO7.
A novel exon was found for one of the RACE products and a
novel combination was observed for another product. For the
six genes analyzed we found evidence for 16 novel isoforms.
We also analyzed expression of two gene loci, namely SYN3
and  TIMP3, in cells in which their expression was not
detected by tiling microarray analysis. SYN3 and TIMP3 are
encoded on opposite strands from one another on chromo-
some 22. SYN3 (Homo sapiens synapsin III mRNA) encodes
a neuronal phosphoprotein that is involved in synaptogenesis
and in the modulation of neurotransmitter release, and it is
implicated in several neuropsychiatric diseases such as schiz-
ophrenia [21,22]. TIMP3 encodes tissue inhibitor of metallo-
proteinase 3. Mutations in this gene have been associated
with the autosomal dominant disorder Sorsby's fundus dys-
trophy [23]. NB4 RNA hybridization to high-density oligonu-
cleotide tiling arrays did not produce signal above
background in the SYN3/TIMP3 region. With RACE sequenc-
ing a number of products were observed. Most RACE
sequences (eight) matched that of the annotated RefSeq iso-
forms for SYN3  (NM_003490.2). RACE sequences also
revealed three other novel isoforms with exon skipping and
intron inclusion (Figure 3a). Similar results were found for
TIMP3. The presence of additional RNA isoforms suggests
that additional messages are probably produced from each
gene locus.
To gain a better understanding of why the SYN3 and TIMP3
genes were not detected by microarray analysis, we examined
their expression level by real-time quantitative PCR. As
shown in Figure 3b, the expression levels of SYN3 and TIMP3
are 1 × 104 and 1 × 105 times lower than that of the HPRT1
transcript. HPRT1 is expressed at low levels in various cell
lines and tissue types, with fewer than 8 to 15 serial analysis
of gene expression (SAGE) tags per 200,000 (<10-5), accord-
ing to the SAGE Anatomic Viewer [24]. Thus, the transcripts
produced by Syn3 and TIMP3 in NB4 cells are present at an
extremely low level.
Table 1
Summary of RACE sequencing using polyA+ and total RNA from human cell lines and tissue
Experiment Number of exon 
primers
Number of novel 
TAR primers
Number of nonTx 
primers
Number of sequence 
reads
Number of detected 
transcripts on the 
genome
1: NB4 total RNA 34 39 0 291 154
2: Hela polyA RNA 0 59 0 273 112
3: placenta total RNA 32 20 44 195 85
4: placenta polyA RNA 0 96 96 591 147
nonTx, region not previously shown to be transcribed; RACE, rapid amplification of cDNA ends; TAR, transcriptionally active region.
Frequency of PCR products obtained from different genomic regions Figure 1
Frequency of PCR products obtained from different genomic regions. 
Primers designed to the sense and antisense strands of exons, novel 
transcriptionally active regions (TARs) and nontranscribed regions were 
used to generate rapid amplification of cDNA ends (RACE) products. The 
frequency of PCR products obtained is indicated. nontx, region not 
previously shown to be transcribed.
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The novel RNA isoforms from annotated genes were exam-
ined for their ability to produce novel protein isoforms. The
16 novel RNAs identified in this study can produce five novel
protein isoforms.
A number of antisense transcripts detected in multiple 
regions appear to be artifacts
Antisense transcription plays diverse and important biologic
roles, and recent studies using reverse transcription based
approaches have reported a large amount of antisense tran-
scription in the human genome [16,19]. Our study employed
primers to analyze transcription from both DNA strands and
thus examined antisense transcription. In addition to detect-
ing transcription from the expected DNA strand, the RACE
experiments produced sequences from the complementary
strand for five of eight known gene loci. These sequences were
revealed in experiments using both natural tissue and cell
lines. However, careful inspection revealed that in most cases
(29 out of 35) the splice junctions of most of the antisense
products are not consistent with the GT-AG, GC-AG, or AT-
AC pattern. Instead, they merely mirror (reverse comple-
ment) the splice junctions of the sense products. Two exam-
ples are shown in Figure 2 for the DRG1 region and the FBX07
regions (known genes on the plus strand). In these regions
large numbers of antisense products (14 and 21, respectively)
were detected on the opposite strand from both 5'-RACE and
3'-RACE reactions. Most of the antisense products lack the
(GT-AG, GC-AG, or AT-AC) consensus splice sequences. It
therefore appears likely that many of these antisense prod-
ucts are derived from the in vitro reverse transcription
reaction, where double strand cDNAs might have formed
[25], or from a complementary RNA in vivo [16].
To investigate further whether the antisnese transcript may
be an artifact due to reverse transcription, we employed a
novel strategy, namely direct chemical labeling of RNA fol-
lowed by strand-specific oligonucleotide tiling microarray
analysis. As shown in Figure 2c for the DRG1 locus, hybridi-
zation of cDNA prepared from NB4 cells using reverse tran-
scriptase to the strand-specific microarray produced both
sense and antisense signals. However, hybridization of RNA
that has been labeled directly by chemical means, thus omit-
ting the use of reverse transcriptase, usually yielded signals
only from the annotated strand. This experiment indicates
the much (but not all) antisense signal is directly tied to the
use of reverse transcriptase and not likely to be present in
vivo.
Novel transcripts and their connectivity
In addition to examining annotated genome regions, we ana-
lyzed a large number of novel TARs by RACE sequencing in
order to gain a better understanding of their structure, their
connectivity to known genes, and whether they might encode
proteins of significant length. In all, 856 RACE reactions were
generated to 214 TARs of the ENCODE regions [18]. End
sequencing of the 5'-RACE and 3'-RACE products on both
strands of the genome revealed overlapping sense and anti-
sense transcripts (Figure 4a). This is consistent with recent
work by Kapronov and coworkers [5,11,26] using RACE
microarray experiments, although they did not analyze the
transcript structure. In addition to analyzing TARs, we
designed primers to 140 regions not known to produce tran-
scripts; 17% of the primers were able to generate a RACE
product whose sequence mapped to the expected region (Fig-
ure 1). Control experiments lacking reverse transcriptase do
not produce products, indicating that the products are
derived from RNA and not contaminating DNA. This fre-
quency of successful RACE products from nonTX regions is
lower than in known exon or novel TAR regions, but it none-
theless indicates that a substantial fraction of the human
genome produces RNA. The transcripts from the nonTx
regions exhibited an interleaved distribution similar to those
from the novel TARs (Figure 4b).
The majority (85%) of the RACE sequences from the TARs
and nonTX regions map contiguously (without introns) to the
genomic sequence. Products from primers that lie close
together on the genome often overlap one another or known
exons, suggesting extensive transcription throughout the
entire region. In addition, whereas the RACE sequences
derived from known exons are mostly connected with known
exons, the sequences from nonTx regions are rarely con-
nected to others (Figure 5a). Although some of the regions
yield results consistent with discrete transcripts, many do
not.
Approximately 16% and 11% of the products produced from
TARs and nonTx regions, respectively, produce transcripts
Distribution of RACE product sequences in the DRG1 and FBX07 regions Figure 2 (see previous page)
Distribution of RACE product sequences in the DRG1 and FBX07 regions. (a) DRG1 Region and (b) FBX07 region. Products from the sense strand (+) are 
shown in the top half of the panel. Products from the antisense strand are in the bottom half of the panel. Blue products are detected sequences from 5'-
rapid amplification of cDNA ends (RACE); red products are detected sequences from 3'-RACE; black indicates refSeq; black asterisks indicate consensus 
splice sites (GT-AG, GC-AG, or AT-AC); and green asterisks indicate novel isoforms with more than 50% consensus splice sites. Note that the antisense 
products that lack consensus splice sites are indicated in lighter colors.(c) cDNA and RNA hybridization signals in DRG1 region. The blue tracks indicate 
the signals that were generated from hybridization of cDNA prepared from NB4 cells using reverse transcriptase to the strand-specific microarray. The 
red tracks indicate hybridization of RNA that has been labeled directly by chemical means, thus omitting the use of reverse transcriptase, to the strand-
specific microarray. Products from the sense strand (+) are shown in the top half of the panel. Products from the antisense strand are in the bottom half 
of the panel.Genome Biology 2008, 9:R3
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Figure 3 (see legend on next page)
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that are spliced with consensus GT-AG, GC-AG, or AT-AC
splice sequences (see Consensus splice site analyses [under
Materials and methods, below]; Figure 5b). This is in contrast
to products produced from exons in which approximately
50% of the messages are spliced. Moreover, further analysis
of the novel TARs revealed that the RNA sequences with con-
sensus splice sites originated from regions with higher micro-
array signal intensity on average than the unspliced ones
(Figure 5c). Microarray signal intensity of the nonTx regions
is close to background for both spliced and unspliced RACE
sequences.
Several newly transcribed regions are likely to produce 
protein
In order to determine better whether the novel transcripts
may be functional, we examined their ability to encode pro-
tein. The sequences of RACE products were analyzed with
respect to whether they contain open reading frames (ORFs)
and/or whether the potential protein coding sequences are
homologous to those in the nonredundant protein database.
For two spliced sequences and 25 unspliced sequences,
potential ORFs were found that have at least 50 codons, and
the predicted protein sequence was homologous to that of a
known protein present in the nonredundant database with a
BLASTX threshold score of 1 × e-9 [27]. The 27 transcripts
contain 20 unique proteins, and nine out of 20 protein encod-
ing ORFs have a translational start and stop codon (11 of the
27 transcripts).
One example of a potential protein coding transcript is shown
i n  F i g u r e  6 .  T h e  n o v e l  t r a n s c r i p t  5 N G S P 2 F 8  d e t e c t e d  b y
RACE end sequencing was properly spliced with a consensus
pattern. It encodes a potential ORF that is 142 codons in
length. Evidence for the transcript is also supported by a
spliced expressed sequence tag (EST), although for
5NGSP2F8 the EST sequence contains a shorter ORF, pre-
sumably through DNA sequencing errors.
We examined the expression level of novel transcript
5NGSP2F8 using real-time quantitative PCR. The 5NGSP2F8
expression level is more than 1,000-fold lower than that of the
HPRT1 transcript, indicating that the gene is expressed at a
low level (Figure 6b).
Discussion
Even though it is estimated that only 20,000 to 25,000 pro-
tein coding genes exist in the human genome, the transcrip-
tome is quite complex and contains protein coding,
nonprotein coding, alternatively spliced, and antisense genes
[28]. RACE sequencing has provided a sensitive means for
probing the human transcriptome. We found that transcripts
from known gene regions often matched the known gene
annotation but that many additional novel transcripts were
also detected. We were also able to detect both novel and
known RNA transcripts from known genes that were not pre-
viously detected in NB4 cells using genomic tiling arrays. It is
thus likely that many (and possibly the majority) of known
genes are expressed and spliced in human tissues and cell
lines, and that multiple transcripts are produced from most
gene loci, at least at a low level.
In addition to many annotated exons, high-density oligonu-
cleotide tiling arrays has identified a large number (8,958) of
novel TARs located in both intronic regions and intergenic
regions distal from previously annotated genes [15,18]. In this
report, end sequencing of the 5'-RACE and 3'-RACE PCR
products from novel TARs identified extensively overlapping
and interconnected novel transcripts. Most of the RACE
sequences from the novel TARs and the nonTX regions are
unspliced. This is consistent with mouse transcriptome stud-
ies, which found the most obvious difference between coding
and noncoding transcripts to be that a higher percentage
(71%) of the noncoding transcripts are unspliced/single
exons, as compared with protein coding transcripts (18%)
[29]. Many human RACE products do not contain long ORFs,
and thus the function of these transcripts is not known. They
probably either represent nonprotein coding RNAs that may
have structural, enzymatic, or regulatory functions; pre-
mRNAs; or RNAs from genomic regions that are transcribed
and present in polyA+ RNA but lack a function.
Although many of the novel RNAs do not have long ORFs, a
subset of them do (about 9%). From our limited study we
found 27 protein coding sequences that are not present in
RefSeq but are likely to encode proteins based on the
presence of a more than 50-codon ORF that is homologous to
other proteins in GenBank. A small fraction (two out of 27) of
these is spliced. Additional studies of the entire human
genome are thus likely to expand the number of protein cod-
ing genes accordingly.
Complementary natural antisense transcripts exert control at
many steps of gene expression in prokaryotes and higher
eukaryotes from transcription to translation, including tran-
script initiation, elongation, mRNA processing, location, and
stability [30,31]. Natural antisense transcripts may be
involved in diverse biologic functions, such as development,
adaptive response, viral infection, and genomic imprinting
[32,33]. In recent years, a large amount of sense-antisense
RACE sequencing can detect transcripts not previously detected by microarray analysis in NB4 cells Figure 3 (see previous page)
RACE sequencing can detect transcripts not previously detected by microarray analysis in NB4 cells. (a) Integrated Genome Browser (IGB) view SYN3 
and TIMP3 rapid amplification of cDNA ends (RACE) products in NB4 RNA. (b) Real-time PCR quantification of SYN3 and TIMP3 transcripts relative to 
HPRT1 in NB4 cells.Genome Biology 2008, 9:R3
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transcription phenomena have been reported in both human
and mouse. In a mouse transcriptome study using the reverse
transcribed cDNA libraries [19], it was indicated that as many
as 72% of all transcriptional units have an antisense tran-
script. In humans, 61% of all transcribed regions were sug-
gested to possess antisense transcript [16]. Our findings that
some antisense transcripts lack consensus splice junctions
and can be detected on strand-specific microarrays only in
cDNA, but not directly labeled RNA, raises the possibility that
many antisense signals are artifacts resulting from reverse
transcription. The conditions that we used are similar to
those used by most other laboratories, suggesting that low
level second strand synthesis is likely to be present in many
studies. Consistent with this, while our manuscript was under
review, Perocchi and coworkers recently reported the
presence of in vitro antisense synthesis in their cDNA prepa-
rations [25]. These findings indicate that much antisense
transcription is due to in vitro synthesis and not in vivo cDNA
synthesis, and therefore caution should be used in interpret-
ing antisense messages. The fact that some antisense regions
still hybridize to directly labeled RNA probes indicates that
some antisense transcripts do exist in vivo.
RACE sequencing was able to uncover novel transcripts from
nontranscribed regions where microarray experiments did
not detect any transcription, indicating the RACE sequence is
more sensitive. This is probably due to the fact that micorar-
ray signals are dampened by cross-hybridization to short oli-
gonucleotides on the array. This problem is especially acute
for genes that have homologous pseudogenes and paralogs.
RACE sequencing offers several other advantages relative to
microarrays. Microarrays do not provide information about
transcript structure, splicing patterns, or the ability of these
regions to encode proteins. Only sequencing full-length
cDNA can resolve these issues. The recent developments of
massively parallel sequencing technology has the potential to
expedite this process greatly [34-37]. A large number of
sequences (400,000 250-bp reads for 454 sequencer [Roche
Applied Science, Indianapolis, IN, USA] and >300 million
approximately 30-bp reads for Solexa sequencer [Illumina
Inc., San Diego, CA, USA]) can readily be obtained in a single
run. Although still relative short, these reads have the poten-
tial to identify novel transcribed regions of the human
genome, and the longer reads m a y  h e l p  t o  i d e n t i f y  n e w
spliced variants [38].
As noted above, quantitative measurements of transcript
expression reveals that two known genes (SYN3 and TIMP3)
are expressed at low levels even in tissues where they have no
obvious role and cannot be detected by standard methods.
Likewise, analysis of novel TARs and even random regions of
the genome indicates that much of the genome produces
transcripts that are present in polyA+ RNA, at least at a low
level. Expression of these RNAs was 103 to 105 times lower
than that of the HPRT gene. Assuming that HPRT is present
at 10-5 (1 copy per 100,000 molecules of the total RNA) in
total RNA, the novel transcripts we detected are present at
10-8 to 10-10 of the total RNA. The finding that much of the
genome is likely to be expressed has previously been reported
for yeast, for which evidence also exists that the RNA is trans-
lated [39,40]. As suggested previously, we speculate that the
ability to express novel regions of the genome continuously
could ultimately be useful in evolution for selecting new
functions.
Our study highlights the enormous complexity of the human
transcriptome and the vast amount of RNA transcripts gener-
ated both from alternative splicing and protein coding and
nonprotein coding RNAs. The ability of RNA to encode pro-
tein and to serve a structural and regulatory role makes it a
diverse molecule for mediating many functions. The remark-
able complexity of RNAs of the human transcriptome coupled
with their diverse functions may therefore help explain the
dramatic increase of complexity in higher eukaryotes and
phenotypic variation [41,42].
Materials and methods
Target selection
The regions of our analysis are selected mainly from the chro-
mosome 22 ENCODE region, with additional targets in chro-
mosome 11 and 21 ENCODE regions. Except for a few regions
for test purposes, we selected most of the exon and novel TAR
primer regions from among those expressed (cell type spe-
cific) regions in known exons and novel TAR regions detected
by transcriptional tiling array experiments. The nontran-
scribed primer regions are selected in a tiled manner from
among those regions that are neither known exons nor novel
TARs.
Primer design
We designed four primers for each targeted region, which can
be exons of known gene, TAR, or previously identified
untranscribed regions. Two gene-specific primers (GSP1 and
GSP2) and two nested GSPs (NGSP1 and NGSP2) on both
plus and minus strand were selected for each targeted region
using a modified Primer3 program. The primers are 23 to 28
nucleotides long, with GC content of 50% to 70% and with Tm
(melting temperature) above 70°C (optimally 73°C to 74°C).
Self-complementary primers that could form hairpin were
RACE products from novel TARs and nonTx regions Figure 4 (see previous page)
RACE products from novel TARs and nonTx regions. (a) novel transcriptionally active regions (TARs) and (b) regions not previously shown to be 
transcribed (nonTx regions). Pink indicates novel TARs, and green nonTx regions that the primers were designed from. Note that the products are 
primarily unspliced.Genome Biology 2008, 9:R3
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avoided. We also voided complementarity between GSPs and
UPM (universal primer A in the SMART RACE™ kit [Clon-
tech, Mountain View, CA, USA]), particularly in their 3' Ends
(UPM long: 5'-CTAATACGACTCACTATAGGGCAAGCAGT-
GGTATCAACGCAGAGT-3'; UPM short: 5'-CTAATACGACT-
CACTATAGGGC-3'). Complementarity between NGSPs and
NUP (nested universal primer A), particularly in their 3' ends,
was avoided (NUP: 5'-AAGCAGTGGTATCAACGCAGAGT-
3'). The primers were mapped against the genome to ensure
Features of the RACE products Figure 5
Features of the RACE products. (a) Connectivity of detected transcripts to known exons/novel transcriptionally active regions (TARs). (b) Frequency of 
splice and unspliced rapid amplification of cDNA ends (RACE) products derived from known exons, novel TARs, and untranscribed regions. (c) Average 
microarray intensities of regions encoding spliced and unspliced RACE products. nontx, region not previously shown to be transcribed.
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Example of a novel transcript detected by RACE sequencing Figure 6
Example of a novel transcript detected by RACE sequencing. (a) Novel transcript 5NGSP2F8 (with consensus splice site) has a potential open reading 
frame of 142 amino acids; also, there is spliced expressed sequence tag (EST) evidence for it. (b) Real-time PCR relative quantification of the novel 
transcript to HPRT1 in placenta polyA+ RNA. RACE, rapid amplification of cDNA ends.
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that they mapped to only one location (with identity <80% to
other locations).
5'-RACE and 3'-RACE experiments, and end 
sequencing
Human NB4 cell line total RNA, Hela S3 polyA+ RNA, pla-
centa total RNA, and polyA+ RNA (Ambion, Austin, TX, USA)
were used in cDNA amplification by SMART RACE™ kit
(Clontech), in accordance with the manufacturer's instruc-
tions [43]. 5'-RACE-Ready cDNA and 3'-RACE-Ready cDNA
were synthesized using PowerScript (Clontech, CA, USA) or
Superscript II (Invitrogen, CA, Carlsbad, USA) moloney
murine leukemia virus reverse transcriptase and SMARTII A
oligo (5'-AAGCAGTGGTATCAACGCAGAGTACGCGGG-3'),
5'-CDS primer A ([5'-(T)25V N-3' (N = A, C, G, or T; V = A, G,
or C)]), or 3'-CDS primer A (5'-AAGCAGTGGTATCAACGCA-
GAGTAC[T]30V N-3' [N = A, C, G, or T; V = A, G, or C]). A
total of 1 μg RNA was used in a final volume of 10 μl reverse
transcription reaction (100 ng/ul). A reverse transcription
reaction without reverse transcriptase was used as negative
control to distinguish genomic DNA contamination. RACE
was followed by PCR amplification using UPM and GSP1 or
GSP2 on both strands of the genome. A 0.5 μl reverse tran-
scription reaction from the above was used in 50 μl of PCR
reaction in the Advantage™ 2 PCR Enzyme System (Clon-
tech). Nested PCRs were performed using NUP (5'-AAG-
CAGTGGTATCAACGCAGAGT-3') and NGSP1 or NGSP2.
One microliter of RACE PCR product was used in a 50 μl reac-
tion. The PCR program was 94°C for 30 seconds and 72°C for
3 minutes, five cycles; then 94°C for 30 seconds, 70°C for 30
seconds and 72°C for 3 minutes, five cycles; followed by 25
cycles of 94°C for 30 seconds and 68°C for 30 seconds; and
concluding with by an extension cycle of 72°C for 3 minutes.
Nested PCR products were end sequenced using NGSP1 or
NGSP2. The RACE sequences have been submitted to Gen-
Bank EST database (accession numbers from EW712308 to
EW712635).
Mapping RACE sequence to the genome
We first use the BLAT alignment tool [44] to compare all the
RACE sequence reads to the human genome assembly (hg17,
May 2004), and then evaluated the 'fitness scores' of the
BLAT output matches using the following formulas:
sizeDif = abs([tEnd - tStart] - [qEnd - qStart]) + abs(qSize - 
[qEnd - qStart])
insertFactor = qNumInsert + tNumInsert
total = matches + repMatches + misMatches
badness = (1,000 × misMatches + insertFactor + 3 × log[1 + 
sizeDif])/total
fitness = 100 - badness × 0.1
Where parameters such as tEnd have the same meanings as
those defined in the BLAT documentation. The fitness score
is based on the 'percent identity score' in the University of
California at Santa Cruz Genome Browser [45], and it
includes additional penalty on small overall matches. Once
these fitness scores have been computed for one RACE exper-
iment, a distribution of these scores was derived based on the
characteristics of those BLAT matches that are located on the
'correct' chromosomes, and only those 'correct' matches with
scores above a certain threshold were kept as 'valid' products
and correspondingly as 'valid' transcripts. See Additional
data file 2 for further details.
Consensus splice site analyses
For those BLAT matches with multiple blocks, the corre-
sponding splice sites in the transcripts were further examined
in the following way. A splice site is defined as a consensus
one if and only if a 'GT-AG' (or 'GC-AG'/'AT-AC', which
appear much less often) pattern can be observed within win-
dows of eight nucleotides on the two ends of it. (For example,
for a splice site starting at chromosome position i and ending
at j, the windows are [i - 3, i + 5) and [j - 5, j + 3].) An overall
consensus score was then assigned to each transcript accord-
ing the proportion of consensus splice sites in all its splicing
events. We also used this consensus splice site criteria to filter
out mirroring antisense transcripts caused by experimental
artifacts. See Additional data files 3 for discussions on the
choice of window size and the resulting transcripts after this
filtering.
Analyzing the correlation of signal intensity and 
transcript characteristics
Normalized signal intensities from across tiling array experi-
ments were extracted for those primer regions and corre-
spondingly assigned to the transcripts. These signal
intensities were correlated with different transcript charac-
teristics such as splicing events in our analysis.
Analyzing the connectivity to known exons/novel TARs
The 'valid' transcripts were also compared against RefSeq
gene annotation [46] and the union of all of the novel TARs
for connectivity information. For each transcript, its connec-
tivity to known RefSeq genes is the number of unique known
exons that overlap with this transcript, and the connectivity
to novel TARs is the number of novel TARs that overlap with
this transcript.
Protein homology analysis of the novel transcripts
We consider a RACE sequence (either a single block one or
with consensus splice sites) a 'novel transcript' if it is not con-
nected to any RefSeq genes. We consider it a 'novel isoform'
of a known gene if it overlaps with a known gene and has at
least 50 bp not covered by existing annotation. We then com-
pared all such novel transcripts to the nonredundant data-
base using BLASTX [27], and selected those transcripts that
have at least 50 amino acids significant matches in the data-http://genomebiology.com/2008/9/1/R3 Genome Biology 2008,     Volume 9, Issue 1, Article R3       Wu et al. R3.13
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base as candidates for further analysis. For the 'novel isoform'
sequences, we then examined whether they encode a different
protein domain.
Real-time RT-PCR
Human NB4 cell line total RNA or placenta polyA+ RNA
(Ambion) were used to make 5'-RACE-Ready cDNA, as
described above. Real-time quantitative PCR experiments
were performed in quadruplication using LightCycler® 480
Probe Master or TaqMan® Universal PCR Master Mix accord-
ing to the manufacturer's instructions on a LightCycler® 480
system (Roche Applied Science, Indianapolis, IN, USA).
Human  HPRT1  endogenous control, human SYN3
(Hs00185853_m1), and TIMP3  (Hs00165949_m1) Taq-
Man®  gene expression assays were ordered from ABI
(Applied Biosystems, Foster City, CA, USA). Real-time quan-
titative PCR primers for novel TAR RACE product 5NGSP2F8
(left primer: tacagcgcagccagaatg; right primer:
gggcaggcaaagtcagataa; ProbeLibrary probe: #87; catalog no.
04689127001) were designed using Universal ProbeLibrary
Assay Design Center [47] (Roche Applied Science). Primers
were designed across a splice junction. The amplicon is 60 bp.
Serial dilutions of cDNA template (400 ng, 100 ng, 25 ng, and
6.25 ng) were used in 20 μl real-time quantitative PCRs. The
PCR program parameter was 50°C for 2 minutes and 95°C for
10 minutes, followed by 45 cycles of 95°C for 15 seconds and
60°C for 1 minute, and a final cooling step of 40°C for 10 sec-
onds. The PCR amplification efficiencies among HPRT1 and
our target transcripts are close (within 10%), and HPRT1
amplification is in the same linear range as our target tran-
scripts. Roche relative quantification software was used to
compare the relative expression levels of our target tran-
scripts with HPRT1.
Direct labeling of total RNA and cDNA and hybridization to 
ENCODE tiling arrays
Total RNA and cDNA from human NB4 cells was chemically
labelled with biotin using ULS reagent from Kreatech
(Amsterdam, The Netherlands) for total RNA and LabelIT
reagent from Mirus Bio (Madison, WI, USA) for cDNA. Five
micrograms of total RNA and cDNA per array hybridization
was incubated with labeling reagent for 30 minutes at 85°C
and 60 minutes at 37°C, respectively. Samples were then
purified with Qiagen PCR purification columns (Qiagen,
Valencia, CA, USA) and ethanol precipitation, respectively.
Labelled samples were hybridized to Affymetrix (Santa Clara,
CA, USA) ENCODE 1.0 oligonucleotide tiling microarrays.
Each sample was hybridized in triplicate to both the forward-
strand and reverse-strand version of the array, using the
manufacturer's standard hybridization, staining, and wash-
ing protocols. The arrays were scanned on an Affymetrix 7G
Plus GeneChip scanner, and the signal intensity data were
processed using a sliding window of 101 bp.
Abbreviations
bp, base pairs; ENCODE, ENCyclopedia Of DNA Elements;
EST, expressed sequence tag; GSP, gene-specific primer;
NGSP, nested gene-specific primer; nonTx region, region not
previously shown to be transcribed; ORF, open reading
frame; RACE, rapid amplification of cDNA ends; RT-PCR,
reverse transcription polymerase chain reaction; SAGE, serial
analysis of gene expression; TAR, transcriptionally active
region; UPM, universal primer A.
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Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 shows examples of
RACE PCR products on an agarose gel. Additional data file 2
contains example of a histogram of the 'fitness scores' of
unique BLAT matches. Additional data file 3 further explains
consensus splice site analyses and shows the squared values
of probabilities computed. Additional data file 4 contains a
file that can be uploaded to University of California at Santa
Cruz Genome Brower to view all RACE products.
Additional data file 1 Examples of RACE PCR products on an agarose gel Shown are examples of RACE PCR products on an agarose gel. Click here for file Additional data file 2 Example of a histogram of the 'fitness scores' of unique BLAT  matches The scores are computed using a subset (from one experiment) of  our first set of RACE sequences, as described in the first row of  Table 1. We then determined a reasonable threshold on these  scores according to the overall distribution of the scores of those  'unique' matches (for every sequence, we choose the match with the  highest score that locates on the expected chromosome, if one  exists). We selected a threshold of 70 for the 'fitness scores',  because this value clearly separates the two sets of matches, which  we can interpret as high-quality and low-quality ones. Clearly, low- ering the threshold will increase the sensitivity of our analysis,  while decreasing the specificity. Click here for file Additional data file 3 Consensus splice site analyses and squared values of probabilities  computed Further explanation of consensus splice site analyses : In order to  decide the window size for the consensus splice site analysis, we  considered a simplified model in which a nucleotide sequence of  length N is generated by randomly selecting A, C, G, T with equal  probability of 1/4, and then computed the probability  (prob_pattern) of that sequence containing at least one pattern of  a consensus splice site (for example, having either 'GT' or 'AG' in  the sequence). This is as follows: prob_pattern(N) =  count_pattern(N)/(4^N), where count_pattern(1) = 0,  count_pattern(2) = 1, count_pattern(N) = 4^(N - 2) -  count_pattern(N - 2) + 4 × count_pattern(N - 1), for N > 2.  Although this formula does not take into account many sophisti- cated factors in reality, it can provide us a good guideline on select- ing the window size for our analysis. This file shows the squared  values of such probabilities (which can be considered as a lower  bound of the probability for a random sequence to have a complete  consensus pattern) for N ranging from 2 to 13. In the analysis of this  paper, we selected the window size to be 8 to ensure at least twofold  enrichment in the number of sequences that we identified com- pared with that in the simplified model, given the same number of  sequences. Click here for file Additional data file 4 All RACE products This file can be uploaded to the University of California at Santa  Cruz Genome Brower to view all RACE products. Click here for file
Acknowledgements
We thank Janine Mok and Dan Gelperin for critical reading of the manu-
script and Jin Lian for NB4 total RNA. We thank Kenneth Nelson and Rajini
Haraksingh for technical assistance. We acknowledge the members of the
Snyder laboratory for help and support. JQ Wu is supported by NIH Ruth
L Kirschstein National Research Service Award and an NIH training grant.
M Snyder and M Gerstein are partially supported by the grants from the
NIH.
References
1. ENCODE Project Consortium: Identification  and analysis of
functional elements in 1% of the human genome by the
ENCODE pilot project.  Nature 2007, 447:799-816.
2. Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N,
Oyama R, Ravasi T, Lenhard B, Wells C, et al.: The transcriptional
landscape of the mammalian genome.  Science 2005,
309:1559-1563.
3. Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT,
Stadler PF, Hertel J, Hackermueller J, Hofacker IL, et al.: RNA maps
reveal new RNA classes and a possible function for pervasive
transcription.  Science 2007, 316:1484-1488.
4. ENCODE Project Consortium: The ENCODE (ENCyclopedia
Of DNA Elements) Project.  Science 2004, 306:636-640.
5. Kapranov P, Willingham AT, Gingeras TR: Genome-wide tran-
scription and the implications for genomic organization.  Nat
Rev Genet 2007, 8:413-423.
6. Harrow J, Denoeud F, Frankish A, Reymond A, Chen CK, Chrast J,
Lagarde J, Gilbert JG, Storey R, Swarbreck D, et al.: GENCODE:Genome Biology 2008, 9:R3
http://genomebiology.com/2008/9/1/R3 Genome Biology 2008,     Volume 9, Issue 1, Article R3       Wu et al. R3.14
producing a reference annotation for ENCODE.  Genome Biol
2006, 7(Suppl 1):1-9.
7. Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH,
Schuler G, Klein SL, Old S, Rasooly R, Good P, MGC Project Team,
et al.: The status, quality, and expansion of the NIH full-length
cDNA project: the Mammalian Gene Collection (MGC).
Genome Res 2004, 14:2121-2127.
8. Wu JQ, Garcia AM, Hulyk S, Sneed A, Kowis C, Yuan Y, Steffen D,
McPherson JD, Gunaratne PH, Gibbs RA: Large-scale RT-PCR
recovery of full-length cDNA clones.  Biotechniques 2004,
36:690-696.
9. Wu JQ, Shteynberg D, Arumugam M, Gibbs RA, Brent MR: Identifi-
cation of rat genes by TWINSCAN gene prediction, RT-
PCR, and direct sequencing.  Genome Res 2004, 14:665-671.
10. Trinklein ND, Karaoz U, Wu J, Halees A, Force Aldred S, Collins PJ,
Zheng D, Zhang ZD, Gerstein MB, Snyder M, et al.: Integrated anal-
ysis of experimental data sets reveals many novel promoters
in 1% of the human genome.  Genome Res 2007, 17:720-731.
11. Denoeud F, Kapranov P, Ucla C, Frankish A, Castelo R, Drenkow J,
Lagarde J, Alioto T, Manzano C, Chrast J, et al.: Prominent use of
distal 5' transcription start sites and discovery of a large
number of additional exons in ENCODE regions.  Genome Res
2007, 17:746-759.
12. Cooper SJ, Trinklein ND, Anton ED, Nguyen L, Myers RM: Compre-
hensive analysis of transcriptional promoter structure and
function in 1% of the human genome.  Genome Res 2006,
16:1-10.
13. Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, Ponjavic
J, Semple CA, Taylor MS, Engstrom PG, Frith MC, et al.: Genome-
wide analysis of mammalian promoter architecture and
evolution.  Nat Genet 2006, 38:626-635.
14. Kim TH, Barrera LO, Qu C, Van Calcar S, Trinklein ND, Cooper SJ,
Luna RM, Glass CK, Rosenfeld MG, Myers RM, et al.: Direct isola-
tion and identification of promoters in the human genome.
Genome Res 2005, 15:830-839.
15. Bertone P, Stolc V, Royce TE, Rozowsky JS, Urban AE, Zhu X, Rinn
JL, Tongprasit W, Samanta M, Weissman S, et al.: Global identifica-
tion of human transcribed sequences with genome tiling
arrays.  Science 2004, 306:2242-2246.
16. Cheng J, Kapranov P, Drenkow J, Dike S, Brubaker S, Patel S, Long J,
Stern D, Tammana H, Helt G, et al.: Transcriptional maps of 10
human chromosomes at 5-nucleotide resolution.  Science
2005, 308:1149-1154.
17. Rinn JL, Euskirchen G, Bertone P, Martone R, Luscombe NM, Hart-
man S, Harrison PM, Nelson FK, Miller P, Gerstein M, et al.: The
transcriptional activity of human chromosome 22.  Genes Dev
2003, 17:529-540.
18. Rozowsky J, Wu J, Lian Z, Nagalakshmi U, Korbel JO, Kapranov P,
Zheng D, Dyke S, Newburger P, Miller P, et al.: Novel transcribed
regions in the human genome.  Cold Spring Harb Symp Quant Biol
2006, 71:111-116.
19. Katayama S, Tomaru Y, Kasukawa T, Waki K, Nakanishi M, Nakamura
M, Nishida H, Yap CC, Suzuki M, Kawai J, et al.: Antisense tran-
scription in the mammalian transcriptome.  Science 2005,
309:1564-1566.
20. Rozowsky JS, Newburger D, Sayward F, Wu J, Jordan G, Korbel JO,
Nagalakshmi U, Yang J, Zheng D, Guigo R, et al.: The DART classi-
fication of unannotated transcription within the ENCODE
regions: associating transcription with known and novel loci.
Genome Res 2007, 17:732-745.
21. Kao HT, Porton B, Czernik AJ, Feng J, Yiu G, Haring M, Benfenati F,
Greengard P: A third member of the synapsin gene family.  Proc
Natl Acad Sci USA 1998, 95:4667-4672.
22. Lachman HM, Stopkova P, Rafael MA, Saito T: Association of schiz-
ophrenia in African Americans to polymorphism in synapsin
III gene.  Psychiatr Genet 2005, 15:127-132.
23. Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ,
Murphy G, Reynolds JJ: Sequence of human tissue inhibitor of
metalloproteinases and its identity to erythroid-potentiating
activity.  Nature 1985, 318:66-69.
24. SAGE Anatomic Viewer   [http://cgap.nci.nih.gov/SAGE/Anatom
icViewer]
25. Perocchi F, Xu Z, Clauder-Munster S, Steinmetz LM: Antisense arti-
facts in transcriptome microarray experiments are resolved
by actinomycin D.  Nucleic Acids Res 2007, 35:e128.
26. Kapranov P, Drenkow J, Cheng J, Long J, Helt G, Dike S, Gingeras TR:
Examples of the complex architecture of the human tran-
scriptome revealed by RACE and high-density tiling arrays.
Genome Res 2005, 15:987-997.
27. Gish W, States DJ: Identification of protein coding regions by
database similarity search.  Nat Genet 1993, 3:266-272.
28. International Human Genome Sequencing Consortium: Finishing
the euchromatic sequence of the human genome.  Nature
2004, 431:931-945.
29. Okazaki Y, Furuno M, Kasukawa T, Adachi J, Bono H, Kondo S,
Nikaido I, Osato N, Saito R, Suzuki H, et al.: Analysis of the mouse
transcriptome based on functional annotation of 60,770 full-
length cDNAs.  Nature 2002, 420:563-573.
30. Hastings ML, Ingle HA, Lazar MA, Munroe SH: Post-transcriptional
regulation of thyroid hormone receptor expression by cis-
acting sequences and a naturally occurring antisense RNA.  J
Biol Chem 2000, 275:11507-11513.
31. Li AW, Murphy PR: Expression of alternatively spliced FGF-2
antisense RNA transcripts in the central nervous system:
regulation of FGF-2 mRNA translation.  Mol Cell Endocrinol
2000, 162:69-78.
32. Kelley RL, Kuroda MI: Noncoding RNA genes in dosage com-
pensation and imprinting.  Cell 2000, 103:9-12.
33. Vanhee-Brossollet C, Vaquero C: Do natural antisense tran-
scripts make sense in eukaryotes?  Gene 1998, 211:1-9.
34. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA,
Berka J, Braverman MS, Chen YJ, Chen Z, et al.: Genome sequenc-
ing in microfabricated high-density picolitre reactors.  Nature
2005, 437:376-380.
35. Brenner S, Johnson M, Bridgham J, Golda G, Lloyd DH, Johnson D,
Luo S, McCurdy S, Foy M, Ewan M, et al.: Gene expression analysis
by massively parallel signature sequencing (MPSS) on
microbead arrays.  Nat Biotechnol 2000, 18:630-634.
36. Gromek K, Kaczorowski T: DNA sequencing by indexer
walking.  Clin Chem 2005, 51:1612-1618.
37. So AP, Turner RF, Haynes CA: Increasing the efficiency of SAGE
adaptor ligation by directed ligation chemistry.  Nucleic Acids
Res 2004, 32:e96.
38. Bainbridge MN, Warren RL, Hirst M, Romanuik T, Zeng T, Go A,
Delaney A, Griffith M, Hickenbotham M, Magrini V, et al.: Analysis of
the prostate cancer cell line LNCaP transcriptome using a
sequencing-by-synthesis approach.  BMC Genomics 2006, 7:246.
39. Ross-Macdonald P, Coelho PS, Roemer T, Agarwal S, Kumar A, Jansen
R, Cheung KH, Sheehan A, Symoniatis D, Umansky L, et al.: Large-
scale analysis of the yeast genome by transposon tagging and
gene disruption.  Nature 1999, 402:413-418.
40. Coelho PS, Kumar A, Snyder M: Genome-wide mutant collec-
tions: toolboxes for functional genomics.  Curr Opin Microbiol
2000, 3:309-315.
41. Mattick JS, Makunin IV: Non-coding RNA.  Hum Mol Genet 2006,
15:R17-R29.
42. Prasanth KV, Spector DL: Eukaryotic regulatory RNAs: an
answer to the 'genome complexity' conundrum.  Genes Dev
2007, 21:11-42.
43. Zhu YY, Machleder EM, Chenchik A, Li R, Siebert PD: Reverse tran-
scriptase template switching: a SMART approach for full-
length cDNA library construction.  Biotechniques 2001,
30:892-897.
44. Kent WJ: BLAT: the BLAST-like alignment tool.  Genome Res
2002, 12:656-664.
45. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM,
Haussler D: The human genome browser at UCSC.  Genome
Res 2002, 12:996-1006.
46. Pruitt KD, Tatusova T, Maglott DR: NCBI Reference Sequence
(RefSeq): a curated non-redundant sequence database of
genomes, transcripts and proteins.  Nucleic Acids Res 2005,
33:D501-D504.
47. Universal ProbeLibrary Assay Design Center   [https://
www.roche-applied-science.com/sis/rtpcr/upl/adc.jsp]